Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

(NY: KNW )

0.2907 -0.0067 (-2.25%)
Official Closing Price Updated: 4:10 PM EDT, Aug 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 181,594
Open 0.2910
Bid (Size) 0.2900 (5)
Ask (Size) 0.3120 (20)
Prev. Close 0.2974
Today's Range 0.2800 - 0.2975
52wk Range 0.2300 - 0.9400
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Know Labs, Inc. Announces $1.655 Million Public Offering
From Know Labs, Inc.
Via Business Wire
KNW Stock Earnings: Know Labs Beats EPS for Q3 2024
KNW stock results show that Know Labs beat analyst estimates for earnings per share the third quarter of 2024. 
Via InvestorPlace

Performance

YTD
-45.61%
-45.61%
1 Month
-7.95%
-7.95%
3 Month
-49.58%
-49.58%
6 Month
-62.83%
-62.83%
1 Year
-60.72%
-60.72%

More News

Read More
Know Labs, Inc. Reports Third Quarter FY 2024 Results
From Know Labs, Inc.
Via Business Wire
Know Labs, Inc. Announces Closing of $3.445 Million Public Offering
From Know Labs, Inc.
Via Business Wire
KNW Stock Earnings: Know Labs Misses EPS for Q2 2024
Via InvestorPlace
Earnings Scheduled For February 14, 2024
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Why Digital Turbine Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Know Labs, Inc. Announces Pricing of $3.445 Million Public Offering
From Know Labs, Inc.
Via Business Wire
Know Labs, Inc. to Host Review of Third Quarter Fiscal Year 2024 Results on August 14, 2024
From Know Labs, Inc.
Via Business Wire
Know Labs Publishes Clinical Results in Leading Diabetes Journal
From Know Labs, Inc.
Via Business Wire
Know Labs to Present at the American Diabetes Association’s Scientific Sessions
From Know Labs, Inc.
Via Business Wire
Know Labs Joins the Industrial Participant Program of the Wyss Institute for Biologically Inspired Engineering at Harvard University
From Know Labs, Inc.
Via Business Wire
Know Labs Appoints Chris Somogyi as President, International
From Know Labs, Inc.
Via Business Wire
Know Labs, Inc. Reports Second Quarter FY 2024 Results
From Know Labs, Inc.
Via Business Wire
Know Labs to Present Clinical Research at the 2024 American Association of Clinical Endocrinology Annual Meeting
From Know Labs, Inc.
Via Business Wire
Know Labs, Inc. to Host Review of Second Quarter Fiscal Year 2024 Results on May 15, 2024
From Know Labs, Inc.
Via Business Wire
Know Labs to Present Clinical Research at the 2024 American Physiology Summit
From Know Labs, Inc.
Via Business Wire
Know Labs’ Non-Invasive Glucose Monitor Achieves 11.1% MARD in Latest Clinical Research Study
From Know Labs, Inc.
Via Business Wire
Why NetApp Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Know Labs Secures U.S. $12 Million Funding for Company’s Further Execution on Its Clinical Research and Development Initiatives
From Know Labs, Inc.
Via Business Wire
Know Labs Announces the KnowU™, its Wearable Non-Invasive Continuous Glucose Monitor
From Know Labs, Inc.
Via Business Wire
Know Labs, Inc. Reports First Quarter FY2024 Results
From Know Labs, Inc.
Via Business Wire
Know Labs, Inc. to Host Review of First Quarter Fiscal Year 2024 Results on February 14, 2024
From Know Labs, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.